This website uses cookies to enhance the user experience.
A

ANANDA AS984 231 202

Counseling
Limited company
Ekraveien 5C 0756 OSLO, Norge
Services
/ Counseling
/ 70.220 Business and other management consultancy activities

ANANDA AS

Keywords

consultingguidanceassistancemanagement issuesstrategicorganizationalreorganizationbusiness procedureschange managementcost reductionpersonnelremunerationpension strategiesproduction planningcontrol planninglobbyingaccounting procedurescost accountingbudget control proceduresrationalizationcontrolmanagement information

Links

Organization

CEO
ER

Erik Rosen1964

Chairman of the board
ER

Erik Rosen1964

Years since formation
23 years
since Feb 21, 2002
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
100,000
1 share class
Total number of shareholders
3
persons

Financials

Total operating income 2024
10,000
NOK
Annual total result 2024
140,952
NOK
Total equity 2024
1,129,483
NOK
Last update: May 28, 2025

Management

Management / administration

NameRoleShares
ER

Erik Rosen

1964

Managing Director/CEO
92 %
directly

Board

NameRoleShares
ER

Erik Rosen

1964

Chairman
92 %
directly
DA

Dag Audun Hagemann Garshol

1965

Alternate Member-

Others

NameRoleShares
T
TRIO REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
ER

Erik Rosen

1964

Managing Director/CEO, Chairman
92 %
directly
BK

Birgitte Kolrud

1969

-
6 %
directly
AK

Anders Kohler Fugelli

1968

-
2 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
ER

Erik Rosen

1964

Ordinary shares
92,000
92 %
BK

Birgitte Kolrud

1969

Ordinary shares
6,000
6 %
AK

Anders Kohler Fugelli

1968

Ordinary shares
2,000
2 %

Shares owned by the ANANDA AS

NameShare classTotal number of sharesShare
C
CHANGETECH AS
Ordinary shares
40,411
9.24 %
B
BILL KILL AS
Ordinary shares
75,477
3.78 %
P
POLYPURE AS
Ordinary shares
40,000
3.23 %
A
AMICOAT AS
NO0010799679
21,213
0.06 %
M
MOSSHYDRO AS
Ordinary shares
38
0.05 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
585
0.02 %
L
LYTIX BIOPHARMA AS
NO0010405780
10,960
0.02 %
P
PHARMA HOLDINGS AS
NO0010797350
124
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
10,000
0
0
0
Annual Total Result
140,952
70,750
142,297
-774,067
Total assets
1,400,801
1,347,595
1,273,350
1,129,679
Total liabilities
271,319
359,065
355,570
354,196
Total equity
1,129,483
988,531
917,780
775,483

P&L

Year2024202320222021
Total operating income
10,000
0
0
0
Total operating costs
18,431
14,500
24,549
68,459
Operating result
-8,431
-14,500
-24,549
-68,459
Financial income/costs
149,383
85,251
166,846
-705,608
Profit before tax
140,952
70,750
142,297
-774,067
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
140,952
70,750
142,297
-774,067

Balance overview

Year2024202320222021
Total fixed assets
260,270
260,270
260,270
260,270
Total current assets
1,140,531
1,087,325
1,013,080
869,409
Total assets
1,400,801
1,347,595
1,273,350
1,129,679
Short term debt
271,319
359,065
355,570
354,196
Long term debt
0
0
0
0
Total liabilities
271,319
359,065
355,570
354,196
Contributed capital
100,000
100,000
100,000
100,000
Retained earnings
1,029,483
888,531
817,780
675,483
Total equity
1,129,483
988,531
917,780
775,483
Total equity and liabilities
1,400,801
1,347,595
1,273,350
1,129,679

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
70
Activity
Activities of head offices; management consultancy activities
70.2
Main industrial group
Management consultancy activities
70.22
Industrial group
Business and other management consultancy activities
70.220
Industrial group
Business and other management consultancy activities